In a previous study, immunohistochemistry was carried out using PAX8 on 102 low-grade serous neoplasms of the ovary, including both SBTs and well-differentiated serous carcinoma, and PAX8 staining was seen in 100% samples [29]. Here, PAX8 is linked to serous adenocarcinoma.